Paul Hudson became CEO of pharmaceutical company Sanofi in September 2019, just months before the COVID-19 pandemic. His company has moved quickly to develop vaccines for the illness. In this episode of Leadership Next, he shares the progress they’ve made. He also shares his enthusiasm for the new technology and tools the company is using to fight disease – COVID-19 of course, but also Parkinson’s, breast cancer and more. Alan Murry asks if Hudson believes his industry will continue to collaborate once the pandemic is under control. Ellen McGirt wonders how he’ll handle the growing number of people who say they won’t accept the COVID-19 vaccine. And of course, because this is Leadership Next, there’s plenty of talk about purpose – Hudson believes refocusing on the company’s purpose has brought energy and innovation to its search for a vaccine.